Our medical and scientific advisory boards

Medical Advisory Board

Pancreatic Cancer UK’s Medical Advisory Board has been established to support the Charity in all its work but with particular emphasis on:

  • Advising the Charity on clinical and scientific developments.
  • Advising our services team on complex clinical queries that arise from service users.
  • Provide input and insight to support the development of information resources for patients, families and carers.
  • Provide input and insight to support the development of our services
  • Provide advice and insight to support the development of our health professional training programme.
  • Provide advice and insight to support the development of policy and campaigning activities and formal positions.
  • Provide input into the selection of priority topics for our Clinical Pioneers Award Scheme, provide peer review of applications and provide recommendations on applications.
  • Providing advice and guidance to the Charity on its approach to involving and engaging health professionals in its work

Board Members:


  • Mr Bill Allum:Consultant Upper GI Surgeon , Royal Marsden NHS Foundation Trust
  • Professor Fiona Campbell, Consultant Gastrointestinal Pathologist, Royal Liverpool University Hospital
  • Mr Ross Carter:Consultant surgeon in Upper GI and Pancreatico-biliary surgery, Glasgow Royal Infirmary
  • Mr Richard Charnley:Consultant surgeon, Freeman Hospital, Newcastle Upon Tyne
  • Saira Chowdhury, Specialist Upper GI Oncology Dietitian, Guy’s & St. Thomas’ Hospital NHS Foundation Trust
  • Dr Pippa Corrie:Consultant and Associate Lecturer in Medical Oncology, Cambridge University Hospitals NHS Foundation Trust
  • Professor David Cunningham:Consultant Medical Oncologist and Head of the Gastrointestinal Unit at The Royal Marsden, Royal Marsden NHS Foundation Trust
  • Dr Damien Durkin: Consultant Pancreaticobiliary Surgeon, Royal Stoke University Hospital
  • Professor Jeff Evans:Professor / Consultant Medical Oncologist, Director of Research Institute of Cancer Sciences, University of Glasgow
  • Mr Giuseppe Kito Fusai:Consultant HPB Surgeon, Royal Free Hospital
  • Dr Sarah Galbraith:Consultant in Palliative Medicine, Addenbrookes Hospital, Cambridge
  • Dr Derek Grose:Consultant Clinical Oncologist and Honorary Senior Lecturer, Beatson West of Scotland Cancer Centre
  • Professor Julia Hippisley-Cox:Professor Clinical Epidemiology & General Practice, University of Nottingham
  • Hemant M Kocher:Professor of Liver and Pancreas Surgery, Barts Cancer Institute, Queen Mary University, London.
  • Dr Murthy Lakkar:Consultant (retired)
  • Dr Stephen Larges:Retired GP
  • Professor Nick Lemoine:Director , Institute of Cancer, Barts and the London School of Medicine and Dentistry,
  • Lena Loia:HPB Clinical Nurse Specialist, Cambridge University Hospitals NHS Foundation Trust
  • Mr Christian Macutkiewicz:Consultant Pancreatic and Laparoscopic Surgeon, Leeds Teaching Hospitals NHS Trust
  • Dr Karen McAdam:Consultant Medical Oncologist, Peterborough City Hospital
  • Alex McAfee:Hepato-Pancreato Biliary Clinical Nurse Specialist (HPB CNS), Belfast Trust
  • Laura McGeeney:Specialist Pancreatic Dietitian, Addenbrooke’s Hospital, Cambridge University Hospitals NHS Foundation Trust
  • Mr Andrew Millar:Consultant Gastroenterologist and Hepatologist, North Middlesex University Hospital and HPB Pathway Director, London Cancer,
  • Professor Henrik Moller:Professor & Director of Cancer Epidemiology and Population Health in KHP Cancer Centre, King’s College London
  • Professor John Neoptolemos:Professor of Surgery, University of Heidelberg, Germany
  • Mr Derek O’Reilly:Consultant Hepatobiliary and Pancreatic Surgeon, Central Manchester University Hospitals
  • Lucie Osborne:Macmillan Brain and CNS Project Manager, Scarborough & Ryedale CCG
  • Professor Steve Pereira:Professor of Hepatology & Gastroenterology, UCL
  • Mary Phillips:Advanced Specialist Dietitian (Hepato-pancreatico-biliary surgery), Royal Surrey County Hospital
  • Dr Ganesh Radhakrishna:Consultant Clinical Oncologist, The Christie Hospital, Manchester
  • Mr Keith Roberts:Consultant Surgeon, University Hospitals Birmingham
  • Sharmila Sothi:Consultant Oncologist, University Hospital and Warwickshire NHS Trust
  • Professor Juan W Valle:Professor / Honorary Consultant of Medical Oncology, The University of Manchester / The Christie NHS Foundation
    Trust, Manchester
  • Philip Whelan:Macmillan CNS , Royal Liverpool and Broadgreen University Hospital
  • Dr Katriina Whitaker:Senior Lecturer and Lead in Cancer Care, University of Surrey
  • Dr Kein Yim:Consultant in Clinical Oncology and Lead Oncologist for Hepatobiliary and Pancreatic Cancer, Velindre Cancer Centre

Scientific Advisory Board

Pancreatic Cancer UK has a Scientific Advisory Board (SAB) with a strong international membership to ensure that funds raised will be spent as effectively as possible.

SAB Chair:


Professor Stephen Smith, International Academic and Health Consultancy (previously Dean of the Faculty of Medicine Dentistry and Health Sciences at the University of Melbourne and Chair Melbourne Health Academic Centre)

A number of distinguished international experts in the field also serve as members of the Board:


  • Professor Carl Borrebaeck, Professor at Department of Immunotechnology, Lund University, Sweden, 2017-present
  • Professor Rajesh Chopra, Head of the Division of Cancer Therapeutics and Director of the Cancer Research UK Cancer Therapeutics Unit, Institute of Cancer Research, London, 2017-present
  • Professor Douglas Fearon, Professor, Cold Spring Harbor Laboratory, USA and University of Cambridge, UK, 2016-present
  • Dr Julie Guillermet-Guibert, INSERM, Toulouse, France, 2017-present
  • Professor Tony Hollingsworth, Associate Director for Basic Research, University of Nebraska, USA, 2017-present
  • Dr Raghu Kalluri, Professor and Chair, MD Anderson Cancer Centre, Texas USA, 2017-present
  • Professor Gillies McKenna, Head of the Department of Oncology, University of Oxford, UK, 2016-present
  • Dr Ilse Rooman, Vrije Universiteit, Belguim, 2017-present
  • Professor Margaret Tempero, Professor of Medicine, Division of Hematology and Oncology, University of California, San Francisco, USA, 2016-present
  • Professor Juan Valle, Professor in Medical Oncology, University of Manchester, UK, 2016-present
  • Professor Daniel Palmer-North West Cancer Research Fund Professor and Honorary Consultant in Medical Oncology, University of Liverpool, UK, Guest member for 2019-20

SAB lay members:


  • Roy Bowdery, UK, 2018-present
  • Michael Stead, UK, 2018-present
  • Katerina Georgiadis, UK, 2018-present
  • Zoë Buckley, UK, 2018-present
  • Stuart McWilliam, UK, Guest member for 2019-20

As part of the scientific review process, the Board provides expert advice to the CEO and Trustees on:

  • Development of the charity’s research strategy and grant giving programme
  • External referees for applications (‘peer reviewers’)
  • Assessment of and final recommendations on applications

The SAB also provides advice and support for the charity on reporting and dissemination of research results.

Previous SAB members:


  • Professor David Tuveson, Director of the Cold Spring Harbor Laboratory, New York, USA, 2010-2016
  • Professor Aldo Scarpa, Università di Verona, Italy, 2010-2017
  • Dr Kyoichi Takaori, Kyoto University, Graduate School of Medicine, Kyoto, Japan, 2013-2017
  • Professor Jim Abbruzzese, Chief of the Division of Medical Oncology and Associate Director for Clinical Research, Duke University, North Carolina, USA, 2010-2019
  • Professor Andrew Biankin, Regius Chair of Surgery/Director of Translational Research Centre, Wolfson Wohl Cancer Research Centre, University of Glasgow, UK, 2010-2019
  • Professor Helmut Friess, Department of Surgery, Technische Universität München, Germany, 2010-2019
  • Professor Francisco Real, Programa de Patología Molecular, Centro Nacional de Investigaciones Oncológicas, Madrid, Spain, 2010-2019
  • Professor Eithne Costello, Pancreas Research Group, Department of Molecular and Clinical Cancer Medicine, University of Liverpool, UK, 2013-2019
  • Professor Nick Lemoine, Director of the Barts Cancer Institute, Barts and the London School of Medicine and Dentistry, University of London, UK, 2013-2019
  • Professor Kenneth Hess, Professor of Biostatistics, MD Andersor Cancer Centre, Texas USA, 2017-2019
  • John Nathan, Lay Member, UK, 2014-2017
  • Catherine McGrath, Lay Member, UK, 2014-2017
  • Dr Anna Gerring, Lay Member, UK, 2018-2019

Clinical Pioneer Award Review Panel 2019-20

Chair:


Professor Stephen Smith, Chair of the Scientific Advisory Board, International Academic and Health Consultancy (previously Dean of the Faculty of Medicine Dentistry and Health Sciences at the University of Melbourne and Chair Melbourne Health Academic Centre)

Panel members:


  • Vicki Stevenson-Hornby, Macmillan HPB Specialist Nurse, Wigan and Leigh Foundation Trust, UK
  • Professor Giuseppe Kito Fusai, Consultant General HPB Surgeon, Royal Free Hospital, UK
  • Dr Naureen Starling, Consultant Medical Oncologist, The Royal Marsden, UK
  • Oonagh Griffin, Senior Pancreatic Dietician, Trinity College Dublin
  • Ilaria Mirabile, Tranformation Lead (Innovation, Treatment and Care), NHS Cancer Programme, NHS England and NHS Improvement, UK
  • Cath Miller, Project Nurse, Leeds Teaching Hospitals NHS Trust, UK
  • Lesley Goodburn, Lay Member, UK
  • Claire Hopkins, Lay Member, UK

Conflicts of Interest Policy

Pancreatic Cancer UK has a rigorous policy on conflicts of interest in relation to both external peer reviewers and members of the SAB. Note that an important part of this policy is that the Chair or Vice Chair will withdraw from the entire research grants round if it includes any applications from members of his own research team.